ITEM 1. BUSINESS We are a direct-to-patient telehealth company providing a high-quality, cost-effective, and convenient way to access comprehensive, virtual and in-home healthcare. We believe the traditional model of visiting a doctor’s office, traveling to a retail pharmacy, and returning for follow-up care or prescription refills is complex, inefficient, and costly which discourages many individuals from seeking much-needed medical care. LifeMD is improving the delivery of the healthcare experience through telehealth with our proprietary technology platform, affiliated and dedicated provider network, broad and expanding treatment capabilities, and the unique ability to nurture patient relationships.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 251M | 212M | 153M | 119M | 93M | 37M |
| Net Income | -8.8M | -22M | -24M | -49M | -62M | -63M |
| EPS | $-0.19 | $-0.53 | $-0.70 | $-1.57 | $-2.29 | $-4.44 |
| Free Cash Flow | 11M | 16M | 8.6M | -23M | -33M | -12M |
| ROIC | -0.5% | -17.6% | -19.6% | -133.7% | -85.9% | -340.8% |
| Gross Margin | 86.9% | 88.7% | 87.6% | 84.3% | 80.6% | 76.2% |
| Debt/Equity | 0.00 | -4.88 | 5.30 | -0.49 | 0.01 | -0.68 |
| Dividends/Share | $0.06 | $0.07 | $0.09 | $0.10 | $0.03 | - |
| Operating Income | -428K | -16M | -14M | -43M | -54M | -58M |
| Operating Margin | -0.2% | -7.6% | -9.5% | -36.5% | -58.5% | -155.0% |
| ROE | -671.2% | - | -676.2% | - | -271.6% | - |
| Shares Outstanding | 48M | 41M | 34M | 31M | 27M | 31M |
LifeMD, Inc. passes 4 of 9 quality checks, suggesting mixed fundamentals.
On a free-cash-flow basis, the stock trades at 16.8x vs a median of 32.7x. The company's 5-year average gross margin is 83.5%. Total shareholder yield (dividends) is 1.7%. At current prices, the estimated annualized return to fair value is +62.6%.
LifeMD, Inc. (LFMD) has a 5-year average return on invested capital (ROIC) of -64.2%. This is below average and may indicate limited pricing power.
LifeMD, Inc. (LFMD) has a market capitalization of $188M. It is classified as a small-cap stock.
Yes, LifeMD, Inc. (LFMD) pays a dividend with a trailing twelve-month yield of 1.65%.
LifeMD, Inc. (LFMD) operates in the Services-Offices & Clinics Of Doctors Of Medicine industry, within the Healthcare sector.
LifeMD, Inc. (LFMD) reported annual revenue of $212 million in its most recent fiscal year, based on SEC EDGAR filings.
LifeMD, Inc. (LFMD) has a net profit margin of -10.3%. The company is currently unprofitable.
LifeMD, Inc. (LFMD) generated $16 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
LifeMD, Inc. (LFMD) reported earnings per share (EPS) of $-0.53 in its most recent fiscal year.
LifeMD, Inc. (LFMD) has a 5-year average gross margin of 83.5%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 13 years of financial data for LifeMD, Inc. (LFMD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
LifeMD, Inc. (LFMD) has a book value per share of $-0.13, based on its most recent annual SEC filing.